Varex Imaging Corporation

Varex Imaging Corporation

VREXยทNASDAQ

$10.15

+2.1%
HealthcareMedical - Devices

Varex Imaging Corporation designs and manufactures X-ray imaging components. The company operates in two segments, Medical and Industrial. The Medical segment designs, manufactures, sells, and services X-ray imaging components comprising X-ray tubes, digital detectors, high voltage connectors, image-processing software and workstations, 3D reconstruction and computer-aided diagnostic software, collimators, automatic exposure control devices, generators, heat exchangers, ionization chambers, and buckys. This segment's products are used in a range of applications, including radiographic and fluoroscopic imaging, mammography, computed tomography, radiation therapy, oncology, CT, cardiac, surgery, dental, computer-aided detection, and other diagnostic radiography uses. The Industrial segment designs, manufactures, sells, and services Linatron X-ray accelerators, X-ray tubes, digital detectors, and high voltage connectors for use in security and industrial inspection applications, such as airport security, cargo screening at ports and borders, and nondestructive testing and examination in various applications. Varex Imaging Corporation sells its products through imaging system original equipment manufacturers, independent service companies, and distributors, as well as directly to end-users. The company has operations in North America, South America, Europe, Russia, the Middle East, India, Africa, Asia, and Australia. Varex Imaging Corporation was founded in 2016 and is based in Salt Lake City, Utah.

At a Glance

Live Snapshot
Market Cap$427.31M
EPS-1.7000
P/E Ratio-5.97
Earnings Date08/06/2026

Intrinsic Alpha Methodology

Thesis Lenses

Signal ยท Driver ยท Risk

Signal

Medium confidence

Valuation multiple is compressed (P/E -6.0).

Valuation inputs: P/E -6.0, earnings yield N/A, momentum +2.1%.

If multiples stay elevated while momentum fades, downside repricing risk rises.

Driver

High confidence

Return profile is soft (ROE -14.9%, ROIC -3.0%).

Profitability stack: net margin -8.3%, ROE -14.9%, ROIC -3.0%.

Quality deterioration often appears in margins before it shows up in headline EPS.

Risk

High confidence

Risk profile is balanced but has notable pressure points to monitor.

Risk factors: liabilities/assets +56.1%, momentum +2.1%, net margin -8.3%.

Higher leverage with weak momentum and thin margins can amplify drawdown severity.

vrex

Varex Imaging Corporation Market vs Earnings Trajectory

VREX ยท NASDAQ

Loading price and EPS data...

Varex Imaging Corporation

Varex Imaging Corporation Fair Value Envelope

VREX ยท NASDAQ

Our analysis suggests that VREX has a fair value of HIDDEN per share in the Base Case projection. With shares currently trading at $10.15, this represents a potential HIDDEN relative to our calculated worth for Varex Imaging Corporation.

Intrinsic Value
Current Price: $10.15
3Y-242.0%
5Y-324.0%
10Y-515.0%
3Y-5.0%
5Y-2.0%
10Y+8.0%
3Y-246.0%
5Y-332.0%
10Y-554.0%
3Y-62.0%
5Y+147.0%
10Y-42.0%
3Y-79.0%
5Y-527.0%
10Y-64.0%
3Y-11.0%
5Y-7.0%
10Y+6.0%
Varex Imaging Corporation

Varex Imaging Corporation Profit Bridge

VREX ยท NASDAQ
Revenue844.60M
Cost of Goods Sold (554.10M)
Gross Profit290.50M
Operating Expenses (318.30M)
Operating Income-27.80M
Interest Expense (35.50M)
Other Income/Expense-31.40M
Pretax Income-59.20M
Income Tax (10.70M)
Net Income-70.30M
Net Income
-70.30M

Profitability Analysis

Gross Margin

34.4%

Moderate margins typical of competitive industries. Monitor for pricing pressure or rising costs.

Operating Margin

-3.3%

Operating losses indicate the core business is unprofitable. Requires restructuring or revenue growth.

Net Profit Margin

-8.3%

Net losses indicate the company is burning cash. Sustainability depends on path to profitability.

Profitability Insight

Margin squeeze alert: Healthy gross margins but weak operating margins suggest excessive operating expenses. Cost optimization could unlock significant value.

34.39%
Gross Profit Margin
9%
3Y+6.0%
5Y+4.0%
10Y+5.0%
-3.29%
Operating Profit Margin
-183%
3Y-138.0%
5Y-132.0%
10Y-413.0%
-8.32%
Net Profit Margin
42%
3Y-254.0%
5Y-336.0%
10Y-519.0%
-14.88%
Return on Equity
67%
3Y-275.0%
5Y-362.0%
10Y-528.0%
-6.35%
Return on Assets
62%
3Y-265.0%
5Y-348.0%
10Y-526.0%
-3.00%
Return on Invested Capital
-89%
3Y-143.0%
5Y-150.0%
10Y-546.0%
VREX

Varex Imaging Corporation Cash Conversion Engine

VREX ยท NASDAQ
Net Income-69.90M
Depreciation & Amortization27.20M
Stock-Based Compensation15.00M
Change in Working Capital-31.40M
Others101.30M
Capital Expenditures-22.90M
Free Cash Flow18.80M

Cash Flow Quality Analysis

FCF Conversion Rate

-26.9%

Negative free cash flow despite positive earnings raises concerns about cash generation ability or heavy capital requirements.

CapEx Intensity

54.9%

Capital-intensive operations require significant reinvestment. Monitor whether CapEx is maintenance or growth-oriented.

FCF Growth Trend

-7.8%

Declining FCF warrants attention. Investigate whether due to temporary factors or fundamental deterioration.

Working Capital Impact

-$31.40M

Significant working capital drain. Growth may be consuming cash through inventory buildup or receivables extensionโ€”monitor closely.

Cash Flow Quality Insight

Working capital strain: Significant cash tied up in operations. Monitor receivables collection, inventory turns, and payment terms to optimize cash conversion cycle.

vrex

Varex Imaging Corporation Funding & Solvency Profile

VREX ยท NASDAQ
Cash & Cash Equivalents85.30M
Net Receivables148.10M
Inventory346.70M
Other Current Assets42.50M
Total Current Assets626 M
Property, Plant & Equipment192.40M
Goodwill & Intangible Assets211.00M
Long-Term Investments20.00M
Other Non-Current Assets37.50M
Total Non-Current Assets250 M
Total Assets
1.09B

Financial Health Analysis

Current Ratio

3.20x

Excellent liquidity position. The company can easily cover its short-term obligations with substantial cushion.

Debt-to-Equity Ratio

1.23x

Elevated leverage. Debt exceeds equity, which amplifies both gains and risks. Monitor debt servicing ability.

Working Capital

430 M

Strong working capital position provides significant operational flexibility and financial cushion.

Asset Composition

57% Current

Balanced asset mix between current and non-current assets, typical of many stable businesses.

vrex

Varex Imaging Corporation Street Expectations Map

VREX ยท NASDAQ

Wall Street analysts project that VREX stock may rise significantly over the coming 12 months. The consensus 1-year price target stands at 14.50, with estimates ranging from a low of 14.50 to a high of 14.50.

Lowest Target
14.50
42.86%
Consensus Target
14.50
42.86%
Highest Target
14.50
42.86%

The consensus 1-year price target stands at 14.50, with estimates ranging from a low of 14.50 to a high of 14.50.

Analyst Consensus Analysis

Upside Potential

+42.9%

Substantial upside potential. Analysts see significant value gap, suggesting the stock may be materially undervalued at current levels.

Analyst Agreement

0.0% spread

High analyst agreement. Narrow target range indicates strong consensus on valuation, suggesting clear investment thesis and predictable outlook.

Analyst Conviction

Very High

Strong buy conviction: High upside with tight consensus suggests compelling investment opportunity backed by analyst confidence.

Market Sentiment Insight

Rare opportunity: Exceptional upside potential with strong analyst consensus creates a compelling setup. The combination of significant price target premium and tight agreement suggests high-conviction undervaluation that may attract institutional capital.

vrex

Varex Imaging Corporation Insider Positioning

VREX ยท NASDAQ

During the last 12 months, insiders have sold $141K worth of VREX shares, with no buying activity reported.

3 Months

Bought

0

0.00

Sold

4.5K

50.24K

Net Activity

-50K

-$50K

3-6 Months

Bought

0

0.00

Sold

0

0.00

Net Activity

+0

+$0

6-9 Months

Bought

0

0.00

Sold

3.2K

39.17K

Net Activity

-39K

-$39K

9-12 Months

Bought

0

0.00

Sold

5.6K

51.48K

Net Activity

-51K

-$51K

Top Buyers

No buying activity

Top Sellers

1
KJK

Kunkel Jay K.

Director

10.1K sharesโ€ข3 transactions

$102K

2
AKL

Aranki Karen L

Officer: Chief Human Resources Officer

3.2K sharesโ€ข1 transactions

$39K

Insider Activity Analysis

Net Insider Sentiment

Bearish

Strong bearish signal with $141K net selling. Heavy insider selling may indicate concerns about valuation or near-term prospects.

Buy/Sell Ratio

0.00:1

Very poor ratio. Heavy selling with minimal buying suggests insiders may be concerned about valuation or outlook.

Recent Trend (3 Months)

$50K

Heavy recent selling activity. Recent insider sales notably exceed purchasesโ€”may warrant investigation into company developments.

Insider Participation

High Selling

2 insider sellers vs. 0 buyers. Widespread selling across multiple insiders may signal concerns.

Insider Activity Insight

Persistent selling pressure: Consistent insider selling with weak buy/sell ratio suggests insiders may be capitalizing on current valuation. Exercise caution and review recent earnings quality and management commentary.

0.00%
Dividend Yield
3Y-
5Y-
10Y-
ย 

vrex Dividend History

VREX
10Y CAGR +0%
Latest $0
Annual $0
Stable dividend payments
Last Period: +0%